» Articles » PMID: 18537096

Independent Associations Between Metabolic Syndrome, Diabetes Mellitus and Atherosclerosis: Observations from the Dallas Heart Study

Overview
Publisher Sage Publications
Date 2008 Jun 10
PMID 18537096
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes mellitus (DM) has been termed a "coronary disease equivalent", yet data suggest that only those DM subjects with metabolic syndrome (MetS) are at increased coronary risk. Using data from the Dallas Heart Study, a large, probability-based population study, we assessed the individual and joint associations between MetS, DM and atherosclerosis, defined as coronary artery calcium (CAC) detected by electron-beam computerised tomography (EBCT) and abdominal aortic plaque (AAP) detected by magnetic resonance imaging. Among 2,735 participants, the median age was 44 years; 1,863 (68%) were non-white; 1,509 (55%) were women; 697 (25.5%) had MetS without DM; 53 (1.9%) had DM without MetS; and 246 (9.0%) had both DM and MetS. The prevalence of CAC increased from those with neither MetS nor DM (16.6%) to MetS only (24.0%) to DM only (30.2%) to both MetS and DM (44.7%) (ptrend <0.0001). The prevalence of CAC was higher in those with both DM and MetS versus either alone (p<0.0001). After adjustment, MetS and DM were each independently associated with CAC (odds ratio [OR] 1.4, 95% confidence intervals [CI] 1.1-1.8; OR 1.8, 95% CI 1.3-2.5, respectively). Compared with the group without DM or MetS, those with both MetS and DM had the most CAC (adjusted OR 2.3; 95% CI 1.6-3.2). All analyses of AAP yielded qualitatively similar results. In conclusion, both MetS and DM are independently associated with an increased prevalence of atherosclerosis, with the highest observed prevalence in subjects with both DM and MetS.

Citing Articles

Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention.

Wong N, Sattar N Nat Rev Cardiol. 2023; 20(10):685-695.

PMID: 37193856 DOI: 10.1038/s41569-023-00877-z.


Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).

Akinmolayemi O, Saldanha S, Joshi P, Deodhar S, Ayers C, Neeland I PLoS One. 2021; 16(9):e0257574.

PMID: 34547056 PMC: 8454977. DOI: 10.1371/journal.pone.0257574.


Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.

Ferreira J, Verma S, Fitchett D, Ofstad A, Lauer S, Zwiener I Cardiovasc Diabetol. 2020; 19(1):200.

PMID: 33243221 PMC: 7694291. DOI: 10.1186/s12933-020-01174-6.


Metabolic syndrome - a risk factor for all-cause disability pension: a prospective study based on the Swedish WOLF cohort.

Liden E, Karlsson B, Toren K, Andersson E Scand J Work Environ Health. 2020; 46(4):402-409.

PMID: 31944257 PMC: 8506307. DOI: 10.5271/sjweh.3881.


The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17.

Yang G, Yuan M, Fu H, Wan G, Li D, Dye T J Diabetes Res. 2019; 2019:5237371.

PMID: 31281851 PMC: 6594276. DOI: 10.1155/2019/5237371.